New York, NY, United States of America

Florian Krammer

USPTO Granted Patents = 12 

 

Average Co-Inventor Count = 3.7

ph-index = 6

Forward Citations = 73(Granted Patents)


Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Florian Krammer in Influenza Research

Introduction: Florian Krammer is a distinguished inventor based in New York, NY. With a remarkable portfolio of 12 patents, he has made significant advancements in the field of influenza virus research. His innovative work focuses on developing novel immunogenic compositions and methods to combat influenza, showcasing his commitment to public health.

Latest Patents: Among his latest patents, Krammer developed a mosaic influenza virus hemagglutinin polypeptide, which is crucial for inducing immune responses against various strains of the virus. This invention involves engineering the hemagglutinin (HA) globular head domain to incorporate amino acid substitutions that enhance its immunogenic potential. Furthermore, his work on chimeric hemagglutinin polypeptides provides methods to generate antibodies, aiding in the fight against influenza virus infections.

Career Highlights: Florian Krammer currently works at the Icahn School of Medicine at Mount Sinai, where he leverages his expertise in virology and immunology. His research aims to create safe and effective vaccines that can provide better protection against influenza viruses, which pose a significant threat to global health.

Collaborations: Throughout his career, Krammer has collaborated with esteemed colleagues like Adolfo Garcia-Sastre and Peter M. Palese. Their joint efforts have further advanced the understanding of influenza virus mechanisms and the development of innovative vaccine strategies.

Conclusion: Florian Krammer’s contributions to influenza research through his patents and collaborations exemplify the role of inventive minds in addressing global health challenges. His ongoing work continues to inspire advancements in vaccine development, aiming to provide improved immunity against influenza.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…